We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIM
251
Regent Investment Management
Kentucky
– -$15K -21,188 Closed
TAM
252
Tocqueville Asset Management
New York
– -$15K -21,043 Closed
SIC
253
Samalin Investment Counsel
New York
– -$15K -21,015 Closed
UBS AM
254
UBS AM
Illinois
– -$14.3K -20,768 Closed
CCG
255
Cypress Capital Group
Florida
– -$14K -20,724 Closed
Calamos Advisors
256
Calamos Advisors
Illinois
– -$14K -20,458 Closed
BSW
257
Buckingham Strategic Wealth
Missouri
– -$14K -20,300 Closed
DY
258
Dowling & Yahnke
California
– -$14K -20,239 Closed
RFC
259
Regions Financial Corp
Alabama
– -$14K -20,131 Closed
TC
260
TradeLink Capital
Illinois
– -$14K -20,000 Closed
BFS
261
Bard Financial Services
Connecticut
– -$13.7M -19,875 Closed
KA
262
Kovack Advisors
Florida
– -$14K -19,822 Closed
Royal London Asset Management
263
Royal London Asset Management
United Kingdom
– -$13K -19,459 Closed
MWM
264
Mission Wealth Management
California
– -$13K -19,409 Closed
HCM
265
Harvey Capital Management
Florida
– -$13K -19,201 Closed
RA
266
Ramius Advisors
New York
– -$13K -18,946 Closed
SG
267
StoneX Group
New York
– -$13K -18,885 Closed
Brown Advisory
268
Brown Advisory
Maryland
– -$29K -18,680 Closed
DADC
269
D.A. Davidson & Co
Montana
– -$12K -17,821 Closed
TSW
270
Thompson Siegel & Walmsley
Virginia
– -$12K -17,637 Closed
SIA
271
Sit Investment Associates
Minnesota
– -$12K -17,485 Closed
KA
272
Kintegral Advisory
New York
– -$12K -17,299 Closed
QI
273
QS Investors
New York
– -$12K -17,126 Closed
ABC
274
Associated Banc-Corp
Wisconsin
– -$12K -17,026 Closed
SWM
275
Sugarloaf Wealth Management
Georgia
– -$12K -16,956 Closed
9 10
11
12 13

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.